CO6300950A2 - Un compuesto de benzodiazepina que bloquea la corriente ikur o el canal kv 1.5 en forma potente y mas selectiva que otros canales de k+ o la corriente i kach (canal girk 1/4) - Google Patents

Un compuesto de benzodiazepina que bloquea la corriente ikur o el canal kv 1.5 en forma potente y mas selectiva que otros canales de k+ o la corriente i kach (canal girk 1/4)

Info

Publication number
CO6300950A2
CO6300950A2 CO10117060A CO10117060A CO6300950A2 CO 6300950 A2 CO6300950 A2 CO 6300950A2 CO 10117060 A CO10117060 A CO 10117060A CO 10117060 A CO10117060 A CO 10117060A CO 6300950 A2 CO6300950 A2 CO 6300950A2
Authority
CO
Colombia
Prior art keywords
channel
current
channels
blocks
compound
Prior art date
Application number
CO10117060A
Other languages
English (en)
Spanish (es)
Inventor
Kenji Tsujimae
Toshiyuki Onogawa
Shinichi Taira
Hokuto Yamabe
Masataka Ueda
Kuninori Tai
Takashi Oshiyama
Yasuhiro Menjo
Shuuji Matsumura
Yasuo Yoga
Sunao Nakayama
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of CO6300950A2 publication Critical patent/CO6300950A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CO10117060A 2008-02-22 2010-09-22 Un compuesto de benzodiazepina que bloquea la corriente ikur o el canal kv 1.5 en forma potente y mas selectiva que otros canales de k+ o la corriente i kach (canal girk 1/4) CO6300950A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008041296 2008-02-22
JP2008227368 2008-09-04

Publications (1)

Publication Number Publication Date
CO6300950A2 true CO6300950A2 (es) 2011-07-21

Family

ID=40600203

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10117060A CO6300950A2 (es) 2008-02-22 2010-09-22 Un compuesto de benzodiazepina que bloquea la corriente ikur o el canal kv 1.5 en forma potente y mas selectiva que otros canales de k+ o la corriente i kach (canal girk 1/4)

Country Status (26)

Country Link
US (2) US8338406B2 (enExample)
EP (1) EP2254873B1 (enExample)
JP (1) JP5355582B2 (enExample)
KR (1) KR101332948B1 (enExample)
CN (2) CN101952259B (enExample)
AR (1) AR070449A1 (enExample)
AU (1) AU2009216079B2 (enExample)
BR (1) BRPI0908132A2 (enExample)
CA (1) CA2715872A1 (enExample)
CO (1) CO6300950A2 (enExample)
CY (1) CY1115220T1 (enExample)
DK (1) DK2254873T3 (enExample)
ES (1) ES2494366T3 (enExample)
HR (1) HRP20140796T1 (enExample)
IL (1) IL207276A (enExample)
MX (1) MX2010009269A (enExample)
MY (1) MY156226A (enExample)
NZ (1) NZ587157A (enExample)
PL (1) PL2254873T3 (enExample)
PT (1) PT2254873E (enExample)
RU (1) RU2496775C2 (enExample)
SI (1) SI2254873T1 (enExample)
TW (1) TWI413522B (enExample)
UA (1) UA103018C2 (enExample)
WO (1) WO2009104819A1 (enExample)
ZA (1) ZA201005469B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101952259B (zh) 2008-02-22 2013-07-03 大塚制药株式会社 苯并二氮杂*化合物及药物组合物
TWI481601B (zh) 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
WO2011021676A1 (ja) 2009-08-21 2011-02-24 大塚製薬株式会社 ベンゾ[b][1,4]ジアゼピン-2,4-ジオン化合物の製造方法
JP2012184225A (ja) * 2011-02-18 2012-09-27 Otsuka Pharmaceut Co Ltd 医薬組成物
JP6240063B2 (ja) 2011-04-28 2017-11-29 ザ ブロード インスティテュート, インコーポレイテッド ヒストンデアセチラーゼ阻害剤
EP2780344A1 (en) 2011-11-15 2014-09-24 Xention Limited Thieno [2, 3 - c]pyrazoles for use as potassium channel inhibitors
AR090037A1 (es) 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
WO2014018979A1 (en) 2012-07-27 2014-01-30 The Broad Institute, Inc. Inhibitors of histone deacetylase
US9914717B2 (en) 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
JOP20190086A1 (ar) * 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
EA038455B1 (ru) * 2016-10-26 2021-08-31 Новартис Аг Новые производные нафтиридинона и их применение в лечении аритмии
CN111108105B (zh) 2017-09-22 2023-03-31 朱比兰特埃皮帕德有限公司 作为pad抑制剂的杂环化合物
KR102782563B1 (ko) 2017-10-18 2025-03-14 주빌런트 에피파드 엘엘씨 Pad 억제제로서의 이미다조-피리딘 화합물
AU2018362046B2 (en) 2017-11-06 2023-04-13 Jubilant Prodel LLC Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
HUE067265T2 (hu) 2017-11-24 2024-10-28 Jubilant Episcribe Llc Heterociklusos vegyületek mint PRMT5 inhibitorok
CN112135610A (zh) 2018-01-12 2020-12-25 KDAc治疗股份有限公司 用于治疗癌症的选择性组蛋白去乙酰酶3(hdac3)抑制剂及免疫治疗剂的组合
EP3765453A1 (en) 2018-03-13 2021-01-20 Jubilant Prodel LLC Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133056A (en) 1961-05-15 1964-05-12 May & Baker Ltd N-phenylpiperazine derivatives of tetrahydrobenzodiazepines
US4001408A (en) 1966-12-14 1977-01-04 Roussel-Uclaf Substituted heterocyclic compounds, processes and composition including those
US3984398A (en) 1966-12-14 1976-10-05 Roussel-Uclaf 1,5-Benzodiazepine-2,4-diones
BE707667A (enExample) 1966-12-14 1968-06-07
JPH0296133A (ja) * 1988-10-01 1990-04-06 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
BR9200951A (pt) 1991-03-21 1992-11-17 Hoffmann La Roche Compostos, processo para sua producao,preparacoes farmaceuticas e uso
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
US5700797A (en) 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
GB0008179D0 (en) 2000-04-05 2000-05-24 Glaxo Group Ltd Chemical process
AU6895000A (en) 1999-08-09 2001-03-05 Merck & Co., Inc. Antiarrhythmic compounds
HRP20040415A2 (en) * 2001-11-13 2005-04-30 3-Dimensional Pharmaceuticals Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
CA2511214C (en) 2002-12-20 2012-12-18 Tularik, Inc. Asthma and allergic inflammation modulators
TWI329641B (en) 2005-08-31 2010-09-01 Otsuka Pharma Co Ltd (benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same
JP4785881B2 (ja) * 2007-02-27 2011-10-05 大塚製薬株式会社 医薬
CN101952259B (zh) 2008-02-22 2013-07-03 大塚制药株式会社 苯并二氮杂*化合物及药物组合物

Also Published As

Publication number Publication date
AU2009216079A1 (en) 2009-08-27
AU2009216079B2 (en) 2013-08-22
MY156226A (en) 2016-01-29
AR070449A1 (es) 2010-04-07
CN103554088A (zh) 2014-02-05
RU2010138928A (ru) 2012-03-27
BRPI0908132A2 (pt) 2015-08-04
CA2715872A1 (en) 2009-08-27
RU2496775C2 (ru) 2013-10-27
EP2254873B1 (en) 2014-06-04
HRP20140796T1 (hr) 2014-10-24
CY1115220T1 (el) 2017-01-04
PL2254873T3 (pl) 2014-10-31
ZA201005469B (en) 2011-11-30
IL207276A0 (en) 2010-12-30
US20130040941A1 (en) 2013-02-14
TW200940067A (en) 2009-10-01
JP5355582B2 (ja) 2013-11-27
CN103554088B (zh) 2016-02-24
JP2011512324A (ja) 2011-04-21
MX2010009269A (es) 2010-09-14
US8664217B2 (en) 2014-03-04
HK1145461A1 (en) 2011-04-21
US8338406B2 (en) 2012-12-25
IL207276A (en) 2014-11-30
CN101952259B (zh) 2013-07-03
CN101952259A (zh) 2011-01-19
TWI413522B (zh) 2013-11-01
ES2494366T3 (es) 2014-09-15
PT2254873E (pt) 2014-08-29
NZ587157A (en) 2012-05-25
US20100331317A1 (en) 2010-12-30
DK2254873T3 (da) 2014-06-30
KR101332948B1 (ko) 2014-01-17
KR20100124781A (ko) 2010-11-29
UA103018C2 (uk) 2013-09-10
SI2254873T1 (sl) 2014-07-31
EP2254873A1 (en) 2010-12-01
WO2009104819A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
CO6300950A2 (es) Un compuesto de benzodiazepina que bloquea la corriente ikur o el canal kv 1.5 en forma potente y mas selectiva que otros canales de k+ o la corriente i kach (canal girk 1/4)
CO6440511A2 (es) Compuesto que contienen nitrogeno y composicion farmaceutica
CO2019000686A2 (es) Compuestos de indol sustituidos con [1,2,4]triazolo[1,5-a]piridinilo
DOP2011000217A (es) Nuevas bencenosulfonamidas como bloqueadores de canales de calcio
CL2017002452A1 (es) Nuevos compuestos bicíclicos
ATE527693T1 (de) Feldeffekttransistor mit einer oxydschicht als kanalschicht und verfahren zu dessen herstellung
ECSP088094A (es) Antagonistas y agonistas de piperazin-piperidina del receptor 5-ht1a
CL2011002838A1 (es) Compuestos derivados de 1,2,4-triazolo[4,3-a]piridina, moduladores alostéricos de receptores mglur2; composición farmacéutica; proceso para prepararla; y su uso en el tratamiento o la prevención de un trastorno del sistema nervioso central seleccionado de ansiedad y esquizofrenia, entre otros.
ME01532B (me) Jedinjenja
MX373121B (es) Composiciones y metodos para el tratamiento de leucemia.
PE20121065A1 (es) Compuestos tetraciclicos
UY39888A (es) Derivados de pirazolo-[3,4-c]piridina como moduladores del receptor p2x7
UY33957A (es) Moduladores de los receptores de hormonas nucleares
MX2019009763A (es) Metodos para tratar esquizofrenia.
PA8795601A1 (es) Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de histamina-3
TW200800958A (en) N-substituted-azacyclylamines as histamine-3 antagonists
BRPI0814772A2 (pt) Indazóis substituídos por 5-piridinona
CL2008002767A1 (es) Compuestos derivados de heterociclico triciclico; composicion farmaceutica; y su uso para el tratamiento de un trastorno mediado por serotonina tal como obesidad, esquizofrenia y disfuncion cognitiva.
AR099071A1 (es) Antagonistas selectivos de nr2b
BRPI0412629A (pt) método de tratamento de disfunção ocular em mamìferos
CU23853B1 (es) Pirimidinil-piperazinas útiles como ligandos del receptor d3/d2
CO6280532A2 (es) Derivados de isoquinolinona como antagonistas de nk3
CR20110348A (es) Derivados de piperidina
PA8781601A1 (es) " derivados de azaciclilbenzamida como antagonistas de histamina-3
ES2533990T3 (es) Antagonistas de receptores opioides de arilpiperazina

Legal Events

Date Code Title Description
FG Application granted